Industry News
Younger T cells may improve immunotherapy for children's cancer
2/12/2016
Pediatric oncologists from The Children's Hospital of Philadelphia (CHOP) have investigated techniques to improve and broaden a novel personalized cell therapy to treat children with cancer.
New milestone for device that can 'smell' prostate cancer
2/12/2016
A research team from the University of Liverpool has reached an important milestone towards creating a urine diagnostic test for prostate cancer that could mean that invasive diagnostic procedures...
How a master regulator in ovarian cancer can go from helpful to harmful
2/12/2016
When it comes to our immune system, dendritic cells serve as a sort of lighthouse for T-cells. These specialized immune cells break down cancer cells into smaller pieces known as antigens.
Alternative proteins encoded by the same gene have widely divergent functions in cells
2/12/2016
It's not unusual for siblings to seem more dissimilar than similar: one becoming a florist, for example, another becoming a flutist, and another becoming a physicist.
Breakable genes may promote disease and brain cell diversity
2/12/2016
Howard Hughes Medical Institute (HHMI) researchers have identified 27 genes in brain stem cells that are prone to a type of DNA damage.
New milestone for device that can 'smell' prostate cancer
2/12/2016
A research team from the University of Liverpool has reached an important milestone towards creating a urine diagnostic test for prostate cancer that could mean that invasive diagnostic procedures...
How a master regulator in ovarian cancer can go from helpful to harmful
2/12/2016
When it comes to our immune system, dendritic cells serve as a sort of lighthouse for T-cells. These specialized immune cells break down cancer cells into smaller pieces known as antigens.
Pancreatic cancer may be treatable with tree extract
2/12/2016
Nimbolide, a natural extract of India's neem tree, shows promise as a chemotherapy agent for the treatment of pancreatic cancer, suggest the results of a new study.
Increasing BRCA testing rates in young women with breast cancer
2/12/2016
Rates of genetic testing for BRCA1 and BRCA2 mutations have increased among women diagnosed with breast cancer at age 40 or younger, according to an article published online by JAMA Oncology.
Adenoviruses (Ad) are everywhere, and while they pose limited threat in individuals with healthy immune systems, they cause significant disease burden in immunocompromised patients.